Wall Street Breakfast Tariff risk flagged as earnings season heats up
Apr 22, 2025
Tariff uncertainty is hitting major players like GE, Kimberly-Clark, and 3M hard. With U.S. tariffs soaring as high as 3,521% on solar imports, companies are bracing for the financial fallout. Meanwhile, Big Pharma is feeling the heat from the White House's drug price plan. The discussion also dives into Amazon's recent stock struggles, highlighting concerns about the broader economic landscape.
AI Snips
Chapters
Transcript
Episode notes
GE Aerospace Navigates Tariff Costs
- GE Aerospace faces tariff-related costs but maintains full-year guidance through cost controls and pricing actions.
- Its strong first-quarter performance and backlog support adjusted EPS expectations near consensus.
3M Adjusts Guidance for Tariffs
- 3M warns tariffs could reduce profit by 20-40 cents per share despite beating Q1 sales estimates.
- The company adjusts 2025 EPS guidance to reflect tariff impacts but keeps the forecast range.
Kimberly-Clark Revises Profit Outlook
- Kimberly-Clark revises profit growth forecast from high single-digit to flat to positive due to tariffs.
- The company expects tariffs to add about $300 million in full-year costs.